Peptide searches are surging because a handful of very different products now share one fashionable word. According to RisingTrends, which tracks consumer search volumes, “NAD peptide” drew 27,100 monthly searches as of September 2026, up 311 percent year over year, while the umbrella term “peptide” reached roughly 1,000,000 monthly searches, up 232 percent. Decode the terms one by one, and the trend gets much less mysterious, and much easier to judge.
This article is general information only. It is not medical advice. Nothing here recommends starting, stopping, or buying any compound. Talk to a qualified medical professional about anything you are considering putting in your body.
What do the peptide search numbers actually show?
The numbers show four separate shopping trips hiding under one keyword. RisingTrends’ November 2026 supplement trends report lists “NAD peptide” at 27,100 monthly searches, up 311 percent year over year, “IV therapy clinics” at 9,900 searches, up 175 percent, “peptide pills” at 4,400 searches, up 132 percent, and “sleep peptides” at 6,600 searches, up 128 percent. Each phrase signals a different intent, a different product category, and a very different level of evidence.
That spread matters more than the headline growth. Some of these searches lead to approved medicines with large clinical trial programs behind them. Others lead to compounds that regulators describe as investigational, sold online under “research use only” labels. Treating the whole trend as one story is how readers end up comparing a prescription drug with decades of data to a powder bought from a website with a disclaimer page. The sections below take the four biggest searches one at a time.
What are people looking for when they search “NAD peptide”?
Most people searching “NAD peptide” are looking for NAD+ treatments, and the first thing worth knowing is that NAD+ is not actually a peptide. NAD+ is a coenzyme found in every living cell, central to energy production and DNA repair. The search phrase blends at least three different things: NAD+ infusions at IV clinics, oral precursor supplements such as NMN and NR that the body converts into NAD+, and general anti-aging content that uses the terms loosely.
The honest evidence summary is narrow. Human trials have established that oral NMN and NR raise NAD+ levels in blood. No human trial has demonstrated that raising NAD+ extends lifespan or clearly slows aging, and long term safety data in humans is still thin. Our full evidence review, “Do NMN or NAD+ Supplements Work for Longevity?“, walks through the trials one by one and reaches the same conclusion: this is a “watch the research” category, not a proven intervention. The +311 percent search growth measures curiosity and marketing reach. It does not measure results.
Why does the wording matter?
Wording matters because “peptide” has become a trust signal in wellness marketing, and attaching it to NAD+ borrows credibility the term has not earned in that context. Peptides are short chains of amino acids. NAD+ is a dinucleotide, a different kind of molecule entirely. When a clinic or a product page calls NAD+ a peptide, it is usually simplifying for sales purposes. That simplification is a reasonable cue to read every other claim on the page more carefully.
What are “sleep peptides,” and what does the evidence actually say?
“Sleep peptides,” up 128 percent to 6,600 monthly searches according to RisingTrends, usually refers to growth hormone secretagogues, compounds that prompt the body to release more of its own growth hormone, which is released in pulses during deep sleep. The names behind most of these searches are CJC-1295 and ipamorelin. RisingTrends’ fitness trends data shows searches for “CJC ipamorelin” at 8,100 a month, up 125 percent year over year, which confirms where the sleep interest is actually pointing.
Here is what the evidence does and does not say. These compounds are real pharmacology, studied for growth hormone deficiency and related conditions, but neither is approved as a sleep treatment, and there is no solid body of human trial evidence showing they improve sleep quality in healthy people. US regulators reviewing substances for pharmacy compounding have flagged CJC-1295 and ipamorelin with safety concerns, including the potential for immune reactions. Growth hormone secretagogues are also prohibited in competitive sport under anti-doping rules. None of that stops the searches, but it should shape how a reader weighs a seller’s claims.
It is also worth separating the compound hunt from the sleep problem itself. Most people typing “sleep peptides” at midnight have a sleep issue, not a peptide deficiency. The evidence base for sleep still runs through the unglamorous basics: consistent timing, light exposure, temperature, and not sabotaging the night with late caffeine or alcohol. Even the trendier sleep hacks deserve the same scrutiny, which is why we graded one of them in “Mouth Taping for Sleep: What the Evidence Says“. A search trend is a map of what people hope will work. It is not a ranking of what does.
Why are so many people searching for “peptide pills”?
“Peptide pills,” up 132 percent to 4,400 monthly searches in the RisingTrends data, is the search of someone who wants peptide results without a needle. The obstacle is basic biology: most peptides are chains of amino acids, and the digestive system treats them the way it treats a piece of chicken, breaking them down before they can act. That is why nearly every well known therapeutic peptide, from insulin onward, is injected.
There are narrow exceptions, and they prove the rule rather than repeal it. An oral form of the GLP-1 drug semaglutide exists, but only because its manufacturer engineered it with a special absorption enhancer and strict dosing conditions, and it remains a prescription medicine, not a supplement. Collagen peptides are the other common “peptide pill,” and they are a different category entirely: broken down fragments of a food protein, sold as a supplement, with a modest and contested evidence base. A website selling an unapproved injectable compound in capsule form, with no prescription and no trial data, is not offering a breakthrough. It is offering the search term, packaged.
Why are “IV therapy clinics” searches up 175 percent?
“IV therapy clinics,” at 9,900 monthly searches and up 175 percent year over year according to RisingTrends, is not really a compound search at all. It is a local services search, and it shows the peptide boom has a storefront. Clinics bundle NAD+ infusions, vitamin drips, and supervised peptide programs into memberships, and the search growth tracks that retail expansion as much as it tracks any scientific development.
What should a reader know before booking? Intravenous delivery skips digestion, so it solves the absorption problem honestly, but it does not solve the evidence problem. For healthy people, the clinical evidence that routine IV nutrient or NAD+ infusions deliver meaningful benefits remains limited, while the costs are substantial and the risks, though usually small in a properly run clinic, include infection and vein complications that no capsule carries. Supervision also varies widely. Our guide to peptide therapy in Los Angeles lays out the questions worth asking any clinic: who supervises medically, whether testing happens before anything is prescribed, and where the products are sourced. Those questions matter more than the menu.
Which peptides are established medicine, and which are investigational?
The cleanest way to cut through the trend is regulatory status, because it tracks the evidence. On the established side sit approved peptide medicines with large human trial programs and regulatory review behind them: insulin, a century old and life sustaining, and the GLP-1 medicines such as semaglutide and tirzepatide, approved for diabetes and weight management after trials involving tens of thousands of patients. Whatever a reader thinks of the GLP-1 era, those products earned their status through a process.
On the other side sit the compounds driving most of the search growth: BPC-157, TB-500, GHK-Cu, epitalon, and the growth hormone secretagogues covered above. These are investigational. None is approved for the wellness uses splashed across the websites selling them, human evidence ranges from preliminary to nearly nonexistent, and much of what circulates comes from animal studies and forum anecdotes. The US Food and Drug Administration has flagged several of these substances, including BPC-157, in its reviews of bulk ingredients for pharmacy compounding, citing significant safety concerns. Products sold as “research chemicals” or “not for human consumption” that are marketed with a wink for human use occupy the riskiest corner of the market, because purity and identity are unverified. A search spike does not move a compound from the second list to the first. Only trials and regulatory review do that.
How should you read a peptide claim before believing it?
Read every peptide claim with four questions, in this order. First, is the compound approved for this use anywhere, or is it investigational? Second, does the claim rest on human trials, or on animal studies and testimonials? Third, who is selling it, and can they document what is actually in the vial or capsule? Fourth, is a licensed clinician involved, with testing before and monitoring after, or is the medical oversight a logo on a checkout page?
Run the four big searches through that filter and the trend resolves into something useful. NAD interest is real, the molecule is legitimate science, and the human benefit beyond raising a blood marker is unproven so far. Sleep peptide interest is mostly interest in two unapproved secretagogues with regulatory flags attached. Peptide pill interest is a wish that biology mostly declines to grant. IV clinic interest is a retail story wearing a lab coat. The searches are worth taking seriously as a cultural signal. They are not, on their own, evidence that any of it works.
The Biohack covers health and longevity research for general information. This article is not medical advice and does not recommend any compound, clinic, or protocol. If you are considering any treatment mentioned here, discuss it with your own physician first.
